Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany
- Status
- WITHDRAWN
- Phase
- N/A
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
- Status
- COMPLETED
- Phase
- N/A
Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Teaching Skin Self-Examination to First-degree Relatives of Melanoma Patients Using Mobile App Technology
- Status
- WITHDRAWN
- Phase
- NA
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
- Status
- COMPLETED
- Phase
- NA
Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.
- Status
- COMPLETED
- Phase
- N/A
Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Melanomas Excised in Primary Care vs Secondary Care Excision
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
- Status
- COMPLETED
- Phase
- N/A
Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Feedback in the Consultation - a Dialogue-based Tool in Personalised Care Planning Using Systematic Patient Involvement
- Status
- COMPLETED
- Phase
- NA
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2